Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Alpine Immune Sciences by Quarter
Alpine Immune Sciences — General and administrative expense ($M) ($M)
Vertex Pharmaceuticals Alpine Immune Sciences: $7.27M in Q1 2024, up 34.6% from a year earlier. That is the highest of the 25 quarters on record here. No newer figure appears in the documents we track.
Where the Q1 2024 figure comes from
Source: SEC Filing ↗
Reported in SEC XBRL (CIK 0001626199 Alpine Immune Sciences).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Alpine Immune Sciences — General and administrative expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 2024 | Mar 31, 2024 | 7.27 | +34.6% | SEC Filing ↗ |
| Q4 2023 | Dec 31, 2023 | 6.37 | +44.8% | SEC Filing ↗ |
| Q3 2023 | Sep 30, 2023 | 5.44 | +18.0% | SEC Filing ↗ |
| Q2 2023 | Jun 30, 2023 | 5.01 | +19.6% | SEC Filing ↗ |
| Q1 2023 | Mar 31, 2023 | 5.40 | +13.2% | SEC Filing ↗ |
| Q4 2022 | Dec 31, 2022 | 4.40 | -3.1% | SEC Filing ↗ |
| Q3 2022 | Sep 30, 2022 | 4.61 | +32.9% | SEC Filing ↗ |
| Q2 2022 | Jun 30, 2022 | 4.19 | +27.4% | SEC Filing ↗ |
| Q1 2022 | Mar 31, 2022 | 4.77 | +46.3% | SEC Filing ↗ |
| Q4 2021 | Dec 31, 2021 | 4.54 | +48.9% | SEC Filing ↗ |
| Q3 2021 | Sep 30, 2021 | 3.47 | +27.1% | SEC Filing ↗ |
| Q2 2021 | Jun 30, 2021 | 3.29 | -1.5% | SEC Filing ↗ |
| Q1 2021 | Mar 31, 2021 | 3.26 | +83.1% | SEC Filing ↗ |
| Q4 2020 | Dec 31, 2020 | 3.05 | +44.5% | SEC Filing ↗ |
| Q3 2020 | Sep 30, 2020 | 2.73 | +10.5% | SEC Filing ↗ |
| Q2 2020 | Jun 30, 2020 | 3.34 | +31.0% | SEC Filing ↗ |
| Q1 2020 | Mar 31, 2020 | 1.78 | -23.9% | SEC Filing ↗ |
| Q4 2019 | Dec 31, 2019 | 2.11 | -15.9% | SEC Filing ↗ |
| Q3 2019 | Sep 30, 2019 | 2.47 | +32.8% | SEC Filing ↗ |
| Q2 2019 | Jun 30, 2019 | 2.55 | +35.6% | SEC Filing ↗ |
| Q1 2019 | Mar 31, 2019 | 2.34 | +10.9% | SEC Filing ↗ |
| Q4 2018 | Dec 31, 2018 | 2.51 | – | SEC Filing ↗ |
| Q3 2018 | Sep 30, 2018 | 1.86 | – | SEC Filing ↗ |
| Q2 2018 | Jun 30, 2018 | 1.88 | – | SEC Filing ↗ |
| Q1 2018 | Mar 31, 2018 | 2.11 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Alpine Immune Sciences ($M), quarterly Q1 2018–Q1 2024 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/alpine-ga-exp
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.